decisionhealth Newsletters, Answer Books - 2006 Issue 7 (July)
Medicare_Claims_Processing_Manual / Chapter_8 / 60.7.2
Subscribe or sign in to view the full article.
Article Overview
This article explains Medicare billing and claims-processing guidance for darbepoetin alfa in the ESRD dialysis setting under Method II. It is aimed at suppliers, DMERCs, and claims staff who need to understand the required claim fields, electronic submission references, and the general handling of coverage-related denials or unprocessable claims. The article also references related Medicare messaging and payment-limit sourcing used in adjudication.
Why This Topic Matters
Suppliers and billing professionals need this guidance to recognize the billing framework Medicare expects for this ESRD-related drug and to understand which claim-processing pathways apply when required information is missing or coverage criteria are not met.
Article Sections
-
Darbepoetin Alfa (Aranesp) Supplier Billing Requirements
Introduces the Medicare billing context for darbepoetin alfa in ESRD dialysis and identifies the claim formats and parties addressed by the guidance.
-
Claim Submission Requirements and Required Information
Describes the claim elements and electronic claim data references discussed for Method II submissions, including where certain billing information is reported.
-
Coverage Handling and Claims Processing
Summarizes how claims are processed when coverage criteria are not met or required information is missing, including the general categories of messages used.
-
Payment and Pricing File Reference
Notes the payment framework referenced for reimbursement and the source cited for obtaining applicable rates.
What You Will Learn
- The Medicare billing context for darbepoetin alfa in ESRD dialysis settings
- Which claim submission formats are referenced for this guidance
- What general claim information Medicare expects to be present
- How coverage-related denials and unprocessable claims are handled at a high level
- Where payment-rate information is referenced in the guidance
Who Should Read This
- Medical billers
- Coding professionals
- ESRD supplier billing staff
- DMERC claims staff
- Revenue cycle teams
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com